Status:

COMPLETED

Microwave Needle Thermoablation for Treatment of Localized Prostate Cancer

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Prostate Cancer

Eligibility:

MALE

45-75 years

Phase:

NA

Brief Summary

Conventional treatment options for localized prostate cancer include prostatectomy, radiotherapy and active surveillance. However, prostatectomy and radiotherapy carry certain degree of morbidity, inc...

Detailed Description

Prostate cancer screening with Prostate specific antigen (PSA) has resulted in an increase in the diagnosis of localized prostate cancer. The traditional approach for treating low-risk and intermediat...

Eligibility Criteria

Inclusion

  • Men aged between 45 - 75 years
  • Life expectancy \> 10 years upon recruitment
  • Localized low or intermediate risk prostate cancer diagnosed on MRI-Ultrasound fusion targeted biopsy
  • Organ-confined prostate cancer on MRI
  • PSA \< 20 ng/mL
  • At least 1 MRI visible lesion present and size ≤15mm, and Targeted biopsy showing Gleason score 6 (with cancer core length ≥6mm) or Gleason score 7 (3+4 or 4+3), With or without positive Systematic biopsy (out of 24 systematic cores) away from MRI visible target showing Gleason 6 cancer

Exclusion

  • Patients unfit for MRI exam or MR gadolinium contrast
  • Patients with previous treatment of prostate cancer
  • Patients with maximal length of target lesion \>15mm
  • Patients with MRI-visible or invisible lesion within 10mm from rectum or 10mm from sphincter on MRI
  • Patients with \>3 areas (MRI-visible or invisible) of prostate cancer
  • Patients with Gleason score 4+4 or any Gleason pattern 5 cancer
  • Patients with bladder pathology including bladder stone and bladder cancer
  • Patients with urethral stricture
  • Patients with neurogenic bladder and/or sphincter abnormalities

Key Trial Info

Start Date :

October 8 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 11 2023

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04113811

Start Date

October 8 2019

End Date

April 11 2023

Last Update

May 7 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Prince of Wales Hospital, Chinese University of Hong Kong

Hong Kong, Hong Kong